Results 141 to 150 of about 42,835 (204)

Dasatinib-Associated Recurrent Symptomatic Bilateral Pleural Effusions in an Elderly Patient With End-Stage Renal Disease on Maintenance Hemodialysis. [PDF]

Cureus
Onuigbo MA, Butler M, Biediger J.
europepmc   +1 more source

DE-ESCALATION OF TYROSINE KINASE INHIBITOR THERAPY IS SAFE IN CHRONIC MYELOID LEUKAEMIA IN DURABLE MOLECULAR RESPONSE (>= MR3 FOR >= 12 MONTHS): INITIAL RESULTS IN THE BRITISH DESTINY STUDY [PDF]

, 2016
Apperley, J, Clark, R, Coffey, T, Copland, M, Foroni, L, O'Brien, S, Pocock, C, Polydoros, F, Salim, R, Smith, G   +9 more
core  

Dasatinib Produces Lengthy Remissions of Extramedullary Leukemia: A Retrospective Observational Study. [PDF]

Eur J Haematol
Cunningham I, Fisher RA, Yang J, Guo Y, Bommhardt U.   +4 more
europepmc   +1 more source

Dasatinib Inhibits Basal B Breast Cancer Through ETS1-Mediated Extracellular Matrix Remodeling. [PDF]

Biomedicines
Guo X, Sun H, Yu F, Feng Y, Guo S, Lei JH, Miao K, Ip KU, Li L, Li H, Liao X, Xu X, Zhou R, Deng CX.   +13 more
europepmc   +1 more source

Adverse reactions of dasatinib in pediatric acute lymphoblastic leukemia: a retrospective comparative cohort study. [PDF]

Transl Pediatr
Yu LT, Xue Q, Feng Q, Wang Z, Zhang SG, Gu JP.   +5 more
europepmc   +1 more source

Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities. [PDF]

Mol Ther Oncol
Mantion CF, Biichlé S, Roussel X, Rolin G, Lejeune A, Labaigt T, Bôle-Richard E, Daguindau E, Royer B, Renosi F, Adotevi O, Loyon R, Fredon M, Garnache-Ottou F.   +13 more
europepmc   +1 more source

Age and gender effects on molecular responses in chronic myeloid leukemia patients by first-line treatment: an Italian CML network cohort study. [PDF]

Ann Hematol
Breccia M, Giai V, Rosso T, Pregno P, Castagnetti F, Bonifacio M, Capodanno I, Tiribelli M, Stagno F, Caocci G, Gozzini A, Patriarca A, Sorà F, Loglisci G, Rossi AR, Coppi MR, Miggiano MC, Di Raimondo F, Galimberti S, Rosti G, Melillo L, Pane F, Saglio G, Ciccone G, Specchia G.   +24 more
europepmc   +1 more source

2B4 co-stimulation and dasatinib modulation enhance anti-CD19 CAR-NK-92 cell cytotoxicity. [PDF]

Front Immunol
Dos Santos MH, de Azevedo JTC, da Silva Januário ME, Schmidt DF, Tirapelle MC, Biggi AFB, Ebrahimabadi S, Silvestre RN, Covas DT, Calado RT, Picanço-Castro V.   +10 more
europepmc   +1 more source

A Novel CIP2A and BCL-XL Clinical Diagnostic Toolkit to Predict Disease Progression and Treatment-Free Remission in Chronic Myeloid Leukaemia. [PDF]

Int J Mol Sci
Basabrain AA, Austin GM, Holcroft AK, Apperley JF, Clark RE, Varadarajan S, Lucas CM.   +6 more
europepmc   +1 more source

Molecular guided therapy leading to exceptional response in relapsed osteosarcoma. [PDF]

Front Pharmacol
Wert E, Menachery L, Hengst J, Arjmandi T, Nagulapally AB, Gandra D, Brown V, Sholler GS, Dandekar S.   +8 more
europepmc   +1 more source